Legacy Wealth Asset Management’s Boston Scientific BSX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.01M	Buy	23,779 +1,668	+8%	+$90.6K	0.22%	123
2026 Q1	$1.39M	Buy	22,111 +1,310	+6%	+$105K	0.34%	72
2025 Q4	$1.98M	Buy	20,801 +561	+3%	+$55K	0.49%	42
2025 Q3	$1.98M	Sell	20,240 -2,226	-10%	-$231K	0.48%	44
2025 Q2	$2.41M	Sell	22,466 -659	-3%	-$66.7K	0.61%	30
2025 Q1	$2.33M	Sell	23,125 -933	-4%	-$93.9K	0.64%	26
2024 Q4	$2.15M	Sell	24,058 -450	-2%	-$39.6K	0.58%	33
2024 Q3	$2.05M	Buy	24,508 +472	+2%	+$37.2K	0.55%	44
2024 Q2	$1.85M	Buy	24,036 +13,303	+124%	+$974K	0.52%	44
2024 Q1	$735K	Hold	10,733	–	–	0.2%	141
2023 Q4	$620K	Sell	10,733 -15	-0.1%	-$801	0.2%	165
2023 Q3	$567K	Buy	10,748 +54	+0.5%	+$2.83K	0.21%	163
2023 Q2	$578K	Sell	10,694 -7,051	-40%	-$368K	0.2%	170
2023 Q1	$888K	Sell	17,745 -214	-1%	-$10.1K	0.32%	92
2022 Q4	$831K	Sell	17,959 -270	-1%	-$11.7K	0.32%	102
2022 Q3	$706K	Sell	18,229 -3,441	-16%	-$138K	0.31%	106
2022 Q2	$808K	Buy	21,670 +256	+1%	+$10.4K	0.33%	119
2022 Q1	$948K	Buy	21,414 +626	+3%	+$27.1K	0.34%	112
2021 Q4	$883K	Buy	20,788 +2,183	+12%	+$91.7K	0.3%	130
2021 Q3	$807K	Buy	18,605 +28	+0.2%	+$1.24K	0.37%	103
2021 Q2	$794K	Buy	18,577 +633	+4%	+$26.6K	0.35%	112
2021 Q1	$694K	Buy	17,944 +427	+2%	+$16.2K	0.32%	130
2020 Q4	$630K	Buy	+17,517	New	+$631K	0.32%	128